Effects of Isotretinoin on Nasal Mucociliary Clearance and Olfactory Function

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Isotretinoin is a common medicine used to treat moderate to severe acne. It often causes dryness of the skin and the inside of the nose. Because a normal sense of smell depends on a healthy nasal lining, this dryness may affect how well a person can smell. This study will examine whether isotretinoin treatment changes the sense of smell in adults with acne. Before starting isotretinoin, participants will complete a standardized smell test and two short questionnaires about nasal symptoms and quality of life (NOSE and SNOT-22). After at least 4 weeks of treatment, the same smell test and questionnaires will be repeated. By comparing results before and after treatment, the study will test the hypothesis that isotretinoin has a negative effect on olfactory function and may reduce patients' ability to smell.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Diagnosed with acne and scheduled to start oral isotretinoin as part of routine dermatology care

• Willing to participate and able to give informed consent

• Not currently smoking

• No history of allergic rhinitis, sinusitis, or active upper respiratory infection

• No medical condition known to affect the sense of smell

Locations
Other Locations
Turkey
Uşak University Faculty of Medicine
RECRUITING
Uşak
Contact Information
Primary
Faruk Kadri Bakkal, MD, Asistant Professor
faruk.bakkal@usak.edu.tr
+905059242255
Backup
Neslihan Demirel Öğüt, MD, Associate Professor
neslihan.ogut@usak.edu.tr
Time Frame
Start Date: 2025-06-01
Estimated Completion Date: 2026-06-01
Participants
Target number of participants: 54
Treatments
Experimental: Isotretinoin Treatment Group
Participants in this arm will receive standard-of-care oral isotretinoin prescribed by the Dermatology Department for the treatment of acne vulgaris. The dosage and duration of isotretinoin therapy will follow routine clinical practice and will be determined by the treating dermatologist. Olfactory function and nasal symptom assessments will be performed before starting isotretinoin and after at least four weeks of treatment.
Related Therapeutic Areas
Sponsors
Leads: Uşak University
Collaborators: The Scientific and Technological Research Council of Turkey

This content was sourced from clinicaltrials.gov